4//SEC Filing
Kafka Steven J. 4
Accession 0001209191-18-001130
CIK 0001488613other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:18 PM ET
Size
8.6 KB
Accession
0001209191-18-001130
Insider Transaction Report
Form 4
Kafka Steven J.
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-01-03$64.00/sh−2,257$144,448→ 88,573 total - Sale
Common Stock
2018-01-02$64.00/sh−157$10,048→ 90,830 total
Footnotes (5)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on December 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.73 to $64.12, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F3]The reporting person previously reported all restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale.
- [F4]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on January 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F5]The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event related to this securities sale.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeother
Related Parties
1- filerCIK 0001585005
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:18 PM ET
- Size
- 8.6 KB